O. A. Haas

MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia

Robert Pirker, J. Wallner, Werner Linkesch et al. · JNCI Journal of the National Cancer Institute · 1991 · 361 citations

Medicine, Molecular Genetics, Oncology +15

Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27

Elisabeth Salzer, Svenja Daschkey, Sharon Choo et al. · Haematologica · 2012 · 173 citations · Full text

Life Sciences, Immunology, Pathology +17

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

I.-M. Huhmann, Herbert Watzke, Heinz Gisslinger et al. · Annals of Hematology · 1996 · 56 citations

Medicine, Oncology, Pharmacotherapy +14

Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study

Florian Thalhammer, Ulrich Jäger, Paul A. Kyrle et al. · Annals of Hematology · 1996 · 53 citations

Medicine, Hematology, Oncology +11

Minimal Residual Disease–based Treatment is Adequate for Relapse-prone Childhood Acute Lymphoblastic Leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALL-BFM 2000 trial

Andishe Attarbaschi, R Panzer-Grümayer, Georg Mann et al. · Klinische Pädiatrie · 2014 · 19 citations

Medicine, Hematology, Oncology +17